Co-Diagnostics amends Maxim equity distribution agreement, removes aggregate sales cap
CODX•Extension of no-issuance covenant
The company extended a no-issuance covenant with May 19, 2026 investors through 5:00 p.m. ET on Aug. 14, 2026.
Amended equity distribution agreement with Maxim
Co-Diagnostics amended its equity distribution agreement with Maxim, removing the fixed cap on aggregate sales of common stock.
Future sales will be limited only by the amount of common stock registered and available under its effective shelf registration statement.
